The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTS
Open accessAbstract
Considerable controversy exists over the purported role of obesity in causing hyperglycemia, hyperlipemia, hyperinsulinemia, and insulin resistance; and the potential beneficial effects of weight reduction remain incompletely defined. Hypertriglyceridemia is one of the metabolic abnormalities proposed to accompany obesity, and in order to help explain the mechanisms leading to this abnormality we have proposed the following sequential hypothesis: insulin resistance --> hyperinsulinemia --> accelerated hepatic triglyceride(TG) production --> elevated plasma TG concentrations. To test this hypothesis and to gain insight into both the possible role of obesity in causing the above metabolic abnormalities and the potential benefit of weight reduction we studied the effects of weight loss on various aspects of carbohydrate and lipid metabolism in a group of 36 normal and hyperlipoproteinemic subjects. Only weak to absent correlations (r = 0.03 - 0.46) were noted between obesity and the metabolic variables measured. This points out that in our study group obesity cannot be the sole, or even the major, cause of these abnormalities in the first place. Further, we have observed marked decreases after weight reduction in fasting plasma TG (mean value: pre-weight reduction, 319 mg/100 ml; post-weight reduction, 180 mg/100 ml) and cholesterol (mean values: pre-weight reduction, 282 mg/100 ml; post-weight reduction, 223 mg/100 ml) levels, with a direct relationship between the magnitude of the fall in plasma lipid values and the height of the initial plasma TG level. We have also noted significant decreases after weight reduction in the insulin and glucose responses during the oral glucose tolerance test (37% decrease and 12% decrease, respectively). Insulin and glucose responses to liquid food before and after weight reduction were also measured and the overall post-weight reduction decrease in insulin response was 48% while the glucose response was relatively unchanged. In a subgroup of patients we studied both the degree of cellular insulin resistance and the rate of hepatic very low density (VLDL) TG production before and after weight reduction. These subjects demonstrated significant decreases after weight reduction in both degree of insulin resistance (33% decrease) and VLDL-TG production rates (40% decrease). Thus, weight reduction has lowered each of the antecedent variables (insulin resistance, hyperinsulinemia, and VLDL-TG production) that according to the above hypothesis lead to hypertriglyceridemia, and we believe the overall scheme is greatly strengthened. Furthermore, the consistent decreases in plasma TG and cholesterol levels seen in all subjects lead us to conclude that weight reduction is an important therapeutic modality for patients with endogenous hypertriglyceridemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
Immunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Electrophoretic separation of plasma lipoproteins in agarose gel
Noble, R. P. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42680-x · Cited by 1,307
A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE
Hoffman, W. S. (1937) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74360-3 · Cited by 1,286
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
Bagdade, J. D., Bierman, E. L., & Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105646 · Cited by 672 · cited 1×
“It has been suggested that obesity has an important causal role in the development of hyperglycemia (1), hyperlipemia (2, 3), hyperinsulinemia (4), and insulin resistance (5).”
BackgroundSalans, L. B., Knittle, J. L., & Hirsch, J. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105705 · Cited by 582
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Role of Insulin in Endogenous Hypertriglyceridemia*
Reaven, G. M., Lerner, R. L., Stern, M. P., & Farquhar, J. W. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105666 · Cited by 511
Self-citationFat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
Self-citationA Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398 · cited 1×
“This approach is based upon the known ability of epinephrine and propranolol to suppress endogenous insulin secretion (32).”
BackgroundMetabolic relationships among the plasma lipoproteins
Wilson, D. E., & Lees, R. S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106896 · Cited by 291
Determination of glycerides in blood serum
Carlson, L. A., & Wadström, L. B. (1959) · Clinica Chimica Acta · doi:10.1016/0009-8981(59)90130-5 · Cited by 272
Coronary Heart Disease: Overweight and Obesity as Risk Factors
KEYS, A., ARAVANIS, C., BLACKBURN, H., VAN BUCHEM, F. S. P., BUZINA, R., DJORDJEVIC, B. S., FIDANZA, F., KARVONEN, M. J., MENOTTI, A., PUDDU, V., et al. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-1-15 · Cited by 243
The Relationship of Cardiovascular Disease to Hyperglycemia
OSTRANDER, L. D., FRANCIS, T., HAYNER, N. S., KJELSBERG, M. O., & EPSTEIN, F. H. (1965) · Annals of Internal Medicine · doi:10.7326/0003-4819-62-6-1188 · Cited by 223
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma
Reaven, G. M., Hill, D. B., Gross, R. C., & Farquhar, J. W. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105290 · Cited by 221
Self-citationFarquhar, J. W., Gross, R. C., Wagner, R. M., & Reaven, G. M. (1965) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39649-8 · Cited by 189
Self-citationThe Glucose Uptake of Human Adipose Tissue in Obesity
Bjöentorp, P., Berchtold, P., Holm, J., & Larsson, B. (1971) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1971.tb00559.x · Cited by 120
Rabinowitz, D. L. (1961) · The Lancet · doi:10.1016/s0140-6736(61)92838-0 · Cited by 116
THE RELATIONSHIP BETWEEN SERUM TRIGLYCERIDES AND SKINFOLD THICKNESS IN OBESE SUBJECTS*
Albrink, M. J., & Meigs, J. W. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34830.x · Cited by 100
Measures of body fat and related factors in normal adults—II
STEINKAMP, R. C., Cohen, N. L., Gaffey, W. R., McKey, T., Bron, G., Siri, W. E., Sargent, T. W., & Isaacs, E. (1965) · Journal of Chronic Diseases · doi:10.1016/0021-9681(65)90162-1 · Cited by 99
IMMUNOASSAY OF INSULIN WITH INSULIN ANTIBODY PRECIPITATE
Stimmler, L. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91306-0 · Cited by 98
Principles of Nutrition and Dietary Recommendations for Patients with Diabetes Mellitus: 1971
Bierman, E. L., Albrink, M. J., Arky, R. A., Connor, W. E., Dayton, S., Spritz, N., & Steinberg, D. I. (1971) · Diabetes · doi:10.2337/diab.20.9.633 · Cited by 96
Hyperinsulinemia and insulin resistance in genetically obese rats
York, D. A., Steinke, J., & Bray, G. A. (1972) · Metabolism · doi:10.1016/0026-0495(72)90070-4 · Cited by 88
Abrams, M. E., Jarrett, R. J., KEEN, H., Boyns, D. R., & Crossley, J. N. (1969) · BMJ · doi:10.1136/bmj.1.5644.599 · Cited by 84
Dietary Management of Hyperlipoproteinemia1
Levy, R. I., BONNELL, M., & Ernst, N. D. (1971) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)13832-5 · Cited by 83
Interactions of Obesity, and Glucose and Insulin Levels in Hypertriglyceridemia
Ford, S., Bozian, R. C., & Knowles, H. C. (1968) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/21.9.904 · Cited by 81
Kalkhoff, R. K., Kim, H. J., Cerletty, J. M., & Ferrou, C. A. (1971) · Diabetes · doi:10.2337/diab.20.2.83 · Cited by 79
Metabolic Changes Associated With Obesity Before and After Weight Reduction
Berkowitz, D. (1964) · JAMA · doi:10.1001/jama.1964.03060190015003 · Cited by 75
Knittle, J. L., & Ginsberg-Fellner, F. (1972) · Diabetes · doi:10.2337/diab.21.6.754 · Cited by 65
Constitutional and Environmental Factors Related to Serum Lipid and Lipoprotein Levels
Harlan, W. R., OBERMAN, A., MITCHELL, R. E., & GRAYBIEL, A. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-3-540 · Cited by 59
Björntorp, P. A., Krotkiewski, M., Larsson, B., & Somlo-Szücs, Z. (1970) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1970.tb04766.x · Cited by 38
Drenick, E. J., Brickman, A. S., & Gold, E. M. (1972) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/25.8.746 · Cited by 29
Smith, M. E., & Levine, R. (1964) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)33408-3 · Cited by 29
Effect of Weight Changes on Serum Insulin Response in Subjects with Normal Oral Glucose Tolerance
Kosáka, K., Hagura, R., ODAGIRI, R., Saito, F., & Kuzuya, T. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-5-655 · Cited by 17
ALIMENTARY AND NONALIMENTARY HYPERGLYCERIDEMIA
Kinsell, L. W., & Schlierf, G. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34823.x · Cited by 15
Stunkard, A. J., & Blumenthal, S. A. (1972) · Metabolism · doi:10.1016/0026-0495(72)90083-2 · Cited by 6
Cited by
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Self-citationChanges in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012
McKeigue, P. M., Shah, B., & Marmot, M. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91164-p · Cited by 1,618
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Self-citation
Metadata
- Authors
- Olefsky, J., Reaven, G. M., & Farquhar, J. W.
- Venue
- Journal of Clinical Investigation
- Published
- 1974-01-01
- Volume
- 53
- Issue
- 1
- Pages
- 64-76
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2027493645
- Cited by
- 510
- References
- 41
- FWCI
- 23.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.